Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
2.33
Oct 20 • 3:59 PM ET Dollar change+0.09 Percentage change(4.02%)
Aftermarket Close
2.30
Aftermarket • 7:30 PM ET Dollar change-0.03 Percentage change(-1.29%)
Index
-
Market Cap
141.52M
Enterprise Value
141.91M
Income
-157.27M
Sales
12.07M
Book/sh
2.88
Cash/sh
0.06
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
21
IPO
Jun 27, 2014
P/E
-
Forward P/E
233.00
PEG
-
P/S
11.72
P/B
0.81
P/C
38.77
P/FCF
-
EV/EBITDA
-
EV/Sales
11.76
Quick Ratio
13.31
Current Ratio
13.31
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
-30.33
EPS next Y
0.01
EPS next Q
-0.01
EPS this Y
11.35%
EPS next Y
100.61%
EPS next 5Y
-
EPS past 3/5Y
96.38% 91.60%
Sales past 3/5Y
97.00% 55.54%
EPS Y/Y TTM
98.48%
Sales Y/Y TTM
3992.20%
EPS Q/Q
99.52%
Sales Q/Q
5774.42%
Insider Own
27.36%
Insider Trans
0.00%
Inst Own
24.53%
Inst Trans
-1.75%
ROA
-171.00%
ROE
-179.01%
ROIC
-92.68%
Gross Margin
95.53%
Oper. Margin
-200.47%
Profit Margin
-1302.78%
SMA20
-8.68%
SMA50
0.05%
SMA200
8.83%
Trades
Shs Outstand
57.42M
Shs Float
44.12M
52W High
7.21 -67.68%
52W Low
1.18 96.62%
Volatility
7.95% 8.59%
ATR (14)
0.19
RSI (14)
45.88
Beta
1.10
Rel Volume
1.56
Avg Volume
394.73K
Volume
617,152
Perf Week
-0.85%
Perf Month
-25.08%
Perf Quarter
34.68%
Perf Half Y
16.50%
Perf YTD
-19.38%
Perf Year
-66.08%
Perf 3Y
-99.96%
Perf 5Y
-100.00%
Perf 10Y
-100.00%
Prev Close
2.24
Price
2.33
Change %
4.02%
Date Action Analyst Rating Change Price Target Change
Apr-23-26Initiated B. Riley Securities Buy $3
Apr-06-26Resumed Maxim Group Buy $4
Mar-24-21Initiated Noble Capital Markets Outperform $20
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jiang Cosmo YiDirectorJun 02 '26Option Exercise0.001,005,0401,0051,005,040Jun 04 08:12 PM
Chee Choon WeeExecutive ChairmanMay 11 '26Option Exercise0.001,109,11801,109,118May 13 07:56 PM
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
CEOMr. Choon Wee Chee
COOMs. Agustina Gani Tjandrasuwita CPA